In 2026, Xinlianxin Shenleng Energy’s medical oxygen was successfully launched into the market, marking a solid step forward for the company in optimizing its product structure and meeting diverse customer needs, and injecting new momentum into its annual market deployment.
As the “Healthy China” strategy continues to advance, medical oxygen — a medical necessity — is widely used in emergency resuscitation, chronic disease treatment, surgical support, and other scenarios, with market demand growing steadily. Leveraging its own technological expertise, Xinlianxin Shenleng Energy has introduced a new medical oxygen product, further refining its product portfolio and providing more reliable options for healthcare customers.
The quality and safety of medical oxygen are of paramount importance. The company strictly adheres to the latest GMP requirements, implementing comprehensive and standardized controls over the production environment, raw material quality, process flows, storage, and transportation — ensuring significant advantages such as high purity, stable quality, and a continuous supply. In addition, given the dual nature of medical oxygen as both a pharmaceutical product and a hazardous chemical, the company has optimized its end-to-end traceability system from production to point of use, effectively guaranteeing that the product is safe, reliable, and traceable.
The company has a dedicated logistics team and its own fleet of transport vehicles, and has established a 24-hour emergency delivery mechanism to ensure efficient response and safe delivery for both routine and urgent oxygen needs — effectively relieving customers of any logistical concerns.
Looking ahead, Xinlianxin Shenleng Energy will continue to deepen its presence in the medical oxygen field, remain customer-centric, steadily expand its product range, enhance service capabilities, and optimize gas supply solutions — contributing to the advancement of the healthcare industry.
Recommended News



